English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Medicine Healthcare & Pharm
中国生物制药(1177.HK)公布2023中期业绩
Aug 25, 2023 19:14 HKT
中國生物製藥(1177.HK)公佈2023中期業績
Aug 25, 2023 19:13 HKT
Sino Biopharmaceutical (1177.HK) Announces 2023 Interim Results
Aug 25, 2023 19:12 HKT
乐普生物公布2023年中期业绩
Aug 25, 2023 18:46 HKT
樂普生物公佈2023年中期業績
Aug 25, 2023 18:45 HKT
华领医药公布2023年中期业绩
Aug 25, 2023 18:22 HKT
華領醫藥公佈2023年中期業績
Aug 25, 2023 18:21 HKT
Hua Medicine Announces 2023 Interim Results
Aug 25, 2023 18:20 HKT
欧康维视公布2023年中期业绩
Aug 24, 2023 23:37 HKT
歐康維視公佈2023年中期業績
Aug 24, 2023 23:36 HKT
Ocumension Therapeutics Announces 2023 Interim Results
Aug 24, 2023 23:35 HKT
Universal Medical Announces 2023 Interim Results
Aug 24, 2023 20:30 HKT
China Medical System Gained Exclusive License of an Anti-Ischemic Stroke Class 1 Innovative Drug
Aug 24, 2023 20:00 HKT
Asia HSE Summit 2023: Taking Health & Safety to The Next Level
Aug 24, 2023 12:55 HKT
中進國際醫療有限公司(NASDAQ:ZJYL)發佈截至2023年3月31日業績公告 總收入同比增長8.3%至10.25百萬美元
Aug 24, 2023 08:25 HKT
中进国际医疗有限公司(NASDAQ:ZJYL)发布截至2023年3月31日业绩公告 总收入同比增长8.3%至10.25百万美元
Aug 24, 2023 08:24 HKT
绿竹生物公布2023年中期业绩
Aug 23, 2023 11:22 HKT
綠竹生物公佈2023年中期業績
Aug 23, 2023 11:21 HKT
Luzhu Biotechnology Announces 2023 Interim Results
Aug 23, 2023 11:20 HKT
The Personalized Lifestyle Medicine Institute Announces the 11th Annual Thought Leaders Consortium
Aug 22, 2023 21:00 HKT
<< Previous  Next >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: